Staar Surgical Jumps; Forward Industries Tumbles
Dow Jones Newswires</br></br>Small stocks began the holidays on a cheerful note, rising for their fourth consecutive session and outpacing their larger brethren Friday.</br></br>Staar Surgical soared $2.74, or 47%, to $8.51. The Food and Drug Administration approved the Monrovia, Calif., ophthalmic-product maker's adult myopia treatment, the Visian Implantable Collamer Lens.</br></br>Forward Industries fell 4.67, or 32%, to 10.05. The Pompano Beach, Fla., designer and marketer of carrying cases cut its fiscal first- quarter revenue guidance to a range of $8.3 million to $8.7 million, lower than its previous forecast of more than $8.9 million.</br></br>Progenics Pharmaceuticals gained 2.51, or 11%, to 25.60. The Tarrytown, N.Y., biopharmaceutical concern entered into an agreement with a division of large-cap Wyeth to jointly develop methylnaltrexone, a treatment for opioid pain medication side effects.